Endometriosis research shifts toward earlier diagnosis and personalized treatment After decades of slow progress, advances in molecular profiling and organoid technology are creating new pathways for non-invasive diagnosis and targeted treatment of endometriosis. Written byBree Foster, PhD

https://www.drugdiscoverynews.com/endometriosis-research-shifts-toward-earlier-diagnosis-and-personalized-treatment-16975?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-8teyMc6F1ooE8hwM22Ji3dwzxwBZy0PQawbzb58I-GaOyph1kv0mteY0uoqlcFcm0HiQkyoIv1tYl5Px2sOnmrZZxbbw&_hsmi=419534051&utm_content=419534051&utm_source=hs_email Endometriosis is traditionally defined as the presence of endometrium-like tissue outside the uterus. While clinically precise, this definition obscures the reality of a disorder that is far more complex than ectopic tissue alone. Endometriosis is now understood as a chronic, multisystem, neuro-inflammatory disease — one that disrupts immune, endocrine, and nervous system function and manifests through pain, fatigue, infertility, and profound reductions in quality of life.